A predicted Francisella tularensis DXD-motif glycosyltransferase blocks immune activation. Issue 1 (1st January 2019)

• Record Type: Journal Article
• Authors: Nau, Gerard J.; Horzempa, Joseph; O'Dee, Dawn; Brown, Matthew J.; Russo, Brian C.; Hernandez, Ana; Dillon, Simon T.; Cheng, Jing; Kane, Lawrence P.; Sanker, Subramaniam; Hukriede, Neil A.
• Is Part Of: Virulence. Volume 10:Issue 1(2019)
• Page Start: 643
• Page End: 656
• Publication Date: 2019-01-01
• Subjects: Francisella tularensis -- glycosyltransferase -- macrophage -- innate immunity -- NFκB -- bacterial pathogenesis -- host-pathogen interactions; Virulence (Microbiology) -- Periodicals; Bacterial diseases -- Periodicals; Molecular microbiology -- Periodicals; 579.05
• DOI: 10.1080/21505594.2019.1631662
• Languages: English
• ISSNs: 2150-5608

Abstract

ABSTRACT: Pathogens enhance their survival during infections by manipulating host defenses. Francisella tularensis evades innate immune responses, which we have found to be dependent on an understudied gene ybeX (FTL_0883/FTT_0615c). To understand the function of YbeX, we sought protein interactors in F. tularensis subsp. holarctica live vaccine strain (LVS). An unstudied Francisella protein co-immunoprecipitated with recombinant YbeX, which is a predicted glycosyltransferase with a DXD-motif. There are up to four genomic copies of this gene with identical sequence in strains of F. tularensis pathogenic to humans, despite ongoing genome decay. Disruption mutations were generated by intron insertion into all three copies of this glycosyltransferase domain containing gene in LVS, gdcA1-3 . The resulting strains stimulated more cytokines from macrophages in vitro than wild-type LVS and were attenuated in two in vivo infection models. GdcA was released from LVS during culture and was sufficient to block NF-κB activation when expressed in eukaryotic cells. When co-expressed in zebrafish, GdcA and YbeX were synergistically lethal to embryo development. Glycosyltransferases with DXD-motifs are found in a variety of pathogens including NleB, an Escherichia coli type-III secretion system effector that inhibits NF-κB by antagonizing death receptor signaling. To our knowledge, GdcA is the first DXD-motif glycosyltransferase that inhibits NF-κB in immune cells. Together, these findings suggest DXD-motif glycosyltransferases may be a conserved virulence mechanism used by pathogenic bacteria to remodel host defenses.